Skip to main content

Table 2 Specifics for the infection repair before reimplantation, such as multiple-stage prosthesis replacement with bone cement spacer or temporary girdlestone, as well as one-stage prosthesis replacement, number of revisions up to reimplantation (median; min -max), time until reimplantation after initiation of infection therapy in months, reimplantation time in minutes, time spent in hospital for treatment, C- reactive protein (CRP) at discharge (mg/dl), Leukocytes at discharge (10exp9)

From: Silver-coated modular Megaendoprostheses in salvage revision arthroplasty after periimplant infection with extensive bone loss – a pilot study of 34 patients

Median (min -max)

Silver- coated group (SCG)

non silver-coated Group (NSCG)

Statistical significance (α = 0.05)

Multiple-stage prosthesis replacement (bone cement spacer)

16/20 (80%)

10/14 (71%)

0.81

Multiple-stage prosthesis replacement (temporary girdlestone)

2/20 (10%)a

1/14 (7%)

0.71

One-stage prosthesis replacement

4/20 (20%)

3/14 (21%)

0.61

Number of revisions up to reimplantation (median; min -max)

4 (0–10)

4 (0–7)

0.19

Time to reimplantation after initiation of infection therapy in months

3 (0–10)

4 (0–24)

0.28

Reimplantation time in minutes

188 (128–236)

193 (122–277)

0.51

Time spent in the hospital for infectious treatment

22 (10–139)

32 (14–158)

0.74

C- reaktive proteine (CRP) at discharge (mg/dl)

17.5 (4.3–89)

18.2 (1.5–89)

0.39

Leukocytes at discharge (10exp9)

7 (5–10.5)

6,6 (4.7–10)

0.92

  1. aIn two cases, both temporary Girdlestone situations and cement spacer therapy were used